The USPTO Director choice may effectively come down to Chris Coons
White House backing for the covid vaccine IP waiver puts the pro-patent Delaware senator in a powerful position to decide who gets the job
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe now